Rankiteo Logo
Rankiteo

The Rankiteo MCP server is now available.

Discover MCP

Top 25 Best Biotechnology Research Companies

Discover the most renowned Biotechnology Research companies, ranked by Rankiteo's proprietary cyber resilience scoring methodology. 214 companies scored.

899
Companies in Industry
214
Scored
756.8
Avg Score
21
Cyber Incidents
Top 25
Shown

Biotechnology Research Cybersecurity Rankings - Best Companies in 2026

The Biotechnology Research sector is home to 899 companies with that Rankiteo actively monitors for cybersecurity resilience. This page presents the Top 25 highest-scoring organizations, ranked by our proprietary Cyber Resilience Score - a composite metric that integrates time-decayed incident exposure, sector-sensitive impact analysis, and market-cap-aware baseline and dampening to produce a single, interpretable score between 100 and 1,000.

Companies at the top of this ranking have the fewest and least-severe recorded cyber incidents - including ransomware attacks, data breaches, and publicly disclosed vulnerabilities. Their scores benefit from clean or near-clean incident histories, favorable industry-level resilience adjustments, and, where applicable, scale-aware baseline anchoring. These organizations serve as benchmarks for what strong cybersecurity posture looks like in the Biotechnology Research industry.

The average cyber resilience score for Biotechnology Research companies with most renowned is currently 756.8 out of 1,000, placing the industry in the Ba–Baa range - adequate but with room for improvement.

Key Insights

835
Highest Score
756.8
Industry Average
4%
Scoring A or Above
21
Recorded Incidents
AI Analysis

Cybersecurity in Biotechnology Research

Generating industry analysis...

Score Distribution

Aaa
0 (0.0%)
Aa
0 (0.0%)
A
9 (4.2%)
Baa
162 (75.7%)
Ba
40 (18.7%)
B
2 (0.9%)
Caa
1 (0.5%)
Ca
0 (0.0%)
C
0 (0.0%)
#CompanyLabelScoreBandIncidentsScore Bar
1
Rocheroche.com
Research and Development in Biotechnology (except Nanobiotechnology)835A0
2
Thermo Fisher Scientificthermofisher.com
Research and Development in Biotechnology (except Nanobiotechnology)826A1
3
Amgenamgen.com
Research and Development in Biotechnology (except Nanobiotechnology)821A1
4
argenxargenx.com
Research and Development in Biotechnology (except Nanobiotechnology)811A0
5
CSLcsl.com
Research and Development in Biotechnology (except Nanobiotechnology)809A0
6
IDEXXidexx.com
Research and Development in Biotechnology (except Nanobiotechnology)809A0
7
Alnylam Pharmaceuticalsalnylam.com
Research and Development in Biotechnology (except Nanobiotechnology)807A0
8
Agilent Technologiesagilent.com
Research and Development in Biotechnology (except Nanobiotechnology)803A0
9
BeiGenebeigene.com
Research and Development in Biotechnology (except Nanobiotechnology)802A0
10
The National Institutes of Healthnih.gov
Research and Development in Biotechnology (except Nanobiotechnology)799Baa0
11
ICON plciconplc.com
Research and Development in Biotechnology (except Nanobiotechnology)796Baa0
12
Gilead Sciencesgilead.com
Research and Development in Biotechnology (except Nanobiotechnology)795Baa2
13
Genentechgene.com
Research and Development in Biotechnology (except Nanobiotechnology)794Baa0
14
Syneos Healthsyneoshealth.com
Research and Development in Biotechnology (except Nanobiotechnology)794Baa0
15
Eurofinseurofins.com
Research and Development in Biotechnology (except Nanobiotechnology)785Baa0
16
Ionis Pharmaceuticals, Inc.ionis.com
Research and Development in Biotechnology (except Nanobiotechnology)783Baa0
17
bioMérieuxbiomerieux.com
Research and Development in Biotechnology (except Nanobiotechnology)782Baa1
18
Merck Life Sciencehttp://www.sigmaaldrich.com
Research and Development in Biotechnology (except Nanobiotechnology)782Baa0
19
Charles River Laboratoriescriver.com
Research and Development in Biotechnology (except Nanobiotechnology)778Baa0
20
Tempus AItempus.com
Research and Development in Biotechnology (except Nanobiotechnology)778Baa0
21
Alexion Pharmaceuticals, Inc.alexion.com
Research and Development in Biotechnology (except Nanobiotechnology)776Baa0
22
Avantoravantorsciences.com
Research and Development in Biotechnology (except Nanobiotechnology)776Baa0
23
Fortreafortrea.com
Research and Development in Biotechnology (except Nanobiotechnology)776Baa0
24
MilliporeSigmahttp://www.sigmaaldrich.com
Research and Development in Biotechnology (except Nanobiotechnology)776Baa0
25
Arcellxarcellx.com
Research and Development in Biotechnology (except Nanobiotechnology)773Baa0

How We Score Biotechnology Research Companies

Rankiteo's Cyber Resilience Score produces a single, interpretable value between 100 and 1,000 for each organization, where higher scores indicate lower estimated cyber risk. The framework integrates three principal components that together balance evidence, context, and comparability across industries and company sizes. Learn more in our AI Cyber Score methodology.

Scoring Components

  • Time-Decayed Incident Exposure (Pinc): Every confirmed cyber incident - ransomware, data breach, cyber attack, or disclosed vulnerability - contributes a penalty weighted by recency and scaled by quantitative severity (financial loss and records exposed). Category-specific base weights reflect real-world impact: ransomware (100 pts), data breach (60 pts), cyber attack (20 pts), and vulnerability (5 pts). Each category decays at a different rate - roughly 3 years for ransomware and data breaches, 2 years for cyber attacks, and 18 months for vulnerabilities - so that older, lower-impact events fade while recent, severe incidents retain lasting influence.
  • Sector-Sensitive Impact Multipliers: Identical incidents carry different weight depending on the industry. Each NAICS sector receives multipliers based on four dimensions: safety-of-life risk, service continuity, regulatory/legal exposure, and data sensitivity. For example, a ransomware attack on a hospital or a utility carries a higher penalty than the same attack on a retail company, reflecting the greater real-world consequences.
  • Market-Cap Baseline & Dampening: A logistic baseline between 750 and 850 anchors each company's starting score based on organizational size. A continuous dampening factor attenuates incident penalties for very large firms, recognizing that larger organizations face higher disclosure rates and typically have greater absorption capacity - without masking genuinely severe events.
  • Industry Adjustment (Aind): A bounded additive term derived from NAICS-level historical incident-rate z-scores. This adjustment rewards companies in historically resilient sectors - but only when they maintain a clean or near-clean incident record. Once any material recent incident occurs, the firm-specific track record dominates the score.
  • Quantitative Severity Scaling: When financial loss or records-exposed data is available, the incident penalty is amplified proportionally - scaled relative to the company's market capitalization so that the same dollar loss has a larger effect on a smaller firm. The combined severity multiplier is capped at 3× to prevent outliers from dominating.
  • Ransomware Recurrence Escalation: Repeated ransomware events within a short timeframe trigger a bounded recurrence multiplier (up to 1.5×), reflecting the elevated systemic risk of persistent adversarial footholds or remediation failures.

Understanding the Bands

Each company's numerical score is also mapped to a letter-grade band for quick comparison. Here is what each band means for Biotechnology Research companies:

  • Aaa (900–1,000): Exceptional cyber resilience. Top-tier security across all measured dimensions.
  • Aa (800–899): Very strong posture with minimal identifiable weaknesses.
  • A (700–799): Strong security practices with some areas for improvement.
  • Baa (600–699): Adequate protection, but notable gaps in security configuration exist.
  • Ba (500–599): Below average. Multiple risk areas require attention.
  • B (400–499): Weak security posture with significant exposure across several categories.
  • Caa (300–399): Very weak. High probability of exploitable vulnerabilities.
  • Ca (200–299): Critically poor security with severe, widespread gaps.
  • C (0–199): Extreme risk. Immediate remediation needed across the board.

Why Biotechnology Research Cybersecurity Matters

As digital transformation accelerates, biotechnology research organizations handle growing volumes of sensitive data - from customer records and financial information to proprietary intellectual property. A breach in this sector can lead to regulatory penalties, reputational damage, operational disruption, and loss of customer trust.

Supply chain risk is another critical factor. Even if your organization is not in the Biotechnology Research sector directly, third-party vendors and partners in this industry may represent a significant part of your supply chain risk profile. Evaluating the cyber resilience of biotechnology research companies helps procurement teams, risk officers, and CISOs make data-driven decisions about vendor selection and ongoing monitoring.

Rankiteo tracks 899 biotechnology research companies with most renowned, updating scores on a continuous basis so you always have the latest view of the industry's cybersecurity landscape.